Cardiovascular Renal Metabolic

Bariatric Surgery: Reduced CVD Risk via PREVENT Equations

Danxia Yu

Watch time: 5m 30s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis

Ellen Apperloo

Watch time: 6m 37s
THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s
AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s
AHA 24: The SELECT Trial

Subodh Verma

Watch time: 5m 7s
AHA 24 Late-Breaking Discussion: REALIZE-K

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s
AHA 24 Late-Breaking Discussion: The SUMMIT Trial

Harriette Van Spall, Milton Packer

Watch time: 17m 22s
AHA 24 Late-Breaking Discussion: The FLOW Trial

Harriette Van Spall,

Watch time: 16m 57s
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease

William Herrington

Watch time: 8m 11s

David Wheeler, Carol Pollock et al

Muthiah Vaduganathan

Sydney Tang et al

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Lee Kaplan, Fatima Cody Stanford, Filip Knop, et al

Andrew JS Coats, Stefan Anker

Neha Pagidipati, Linda Mellbin et al

Watch time: 2h (19 videos)

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Debbie L Cohen , Raymond R Townsend

Raymond B Fohtung , Michael W Rich

Read time: 13m 29s

Paul Kalra

Watch time: 12m 41s (2 videos)

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s

Media

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
Bariatric Surgery: Reduced CVD Risk via PREVENT Equations

Danxia Yu

Watch time: 5m 30s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
Insights from EMPA-Kidney: Methodology, Data & Impact

Kate Wilcox, David Preiss

Watch time: 38m 47s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis

Ellen Apperloo

Watch time: 6m 37s
ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Harriette Van Spall, James L Januzzi

Watch time: 23m 6s

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)
Risk For Heart Failure Modulate The Effectiveness Of Empagliflozin ? with Javed Butler

Javed Butler

Watch time: 5m 13s
ACC 2018: Canagliflozin & heart failure in type 2 diabetes

Gemma Figtree

Watch time: 3m 13s
HFA 2020: Prospective analysis of DAPA-HF

Watch time: 6m 52s
HFA 2020: Dapagliflozin and diuretic use in patients with HFrEF in DAPA-HF

Alice Jackson

Watch time: 6m 56s

Articles

HDL Cholesterol and Adverse Outcomes

Marc P Allard-Ratick

,

Pratik Sandesara

,

Arshed A Quyyumi

,

Laurence S Sperling

,

Published:

12 March 2019

Citation:

US Cardiology Review 2019;13(1):49–53

DOI:

https://doi.org/10.15420/usc.2019.3.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 5380
  • Downloads: Downloads 42
  • Citations: 9

Diabetic Cardiomyopathy: Five Major Questions with Simple Answers

Miguel Alejandro Rodriguez-Ramos

,

Published:

12 March 2019

Citation:

US Cardiology Review 2019;13(1):46–8

DOI:

https://doi.org/10.15420/usc.2018.18.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1947
  • Downloads: Downloads 26

Diabetes Drugs and Cardiovascular Event Reduction: A Paradigm Shift

Erik M Kelly

,

Donald E Cutlip

,

Citation:

US Cardiology Review 2018;12(1):46–50.

DOI:

https://doi.org/10.15420/usc.2017:35:1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2023
  • Downloads: Downloads 9

Recognition, Diagnosis, and Management of Heart Failure with Preserved Ejection Fraction

Meshal Soni

,

Edo Y Birati

,

Citation:

US Cardiology Review 2018;12(1):8–12.

DOI:

https://doi.org/10.15420/usc.2017:21:1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2410
  • Downloads: Downloads 35